Mary Greeley Medical Center
About Mary Greeley Medical Center
"Mary Greeley is a 220-bed regional hospital that provides healthcare to the residents of a 13-county area in central Iowa. The counties include Story, Boone, Marshall, Greene, Hamilton, Hardin, Sac, Calhoun, Wright, Carroll, Tama, Dallas and Polk."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
93
SWOG Cancer Research Network
39
Alliance for Clinical Trials in Oncology
27
ECOG-ACRIN Cancer Research Group
17
NRG Oncology
7
Gynecologic Oncology Group
4
Eastern Cooperative Oncology Group
2
GOG Foundation
1
Pfizer
1
Wake Forest University Health Sciences
1
Clinical Trials at Mary Greeley Medical Center
During the past decade, Mary Greeley Medical Center conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 54 clinical trials were completed, i.e. on
average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 36 clinical trials were completed. i.e. 53.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
2009-07-15
2021-06-15
Completed
506
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
2009-06-29
2024-07-28
Active, not recruiting
813
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
2009-07-15
2022-02-08
Completed
1,333
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
2009-11-17
2023-12-31
Active, not recruiting
545
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
2010-02-15
2018-08-15
Completed
356
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
2010-04-12
Active, not recruiting
341
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mary Greeley Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 93 trials, followed by "SWOG Cancer Research Network" with 39 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology"
with 17 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Greeley Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 97 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Mary Greeley Medical Center
According to Clinical.Site data, the most researched conditions in "Mary Greeley Medical Center" are
"Stage IV Lung Cancer AJCC v8" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IVA Lung Cancer AJCC v8" (9 trials), "Stage IVB Lung Cancer AJCC v8" (9 trials) and "Invasive Breast Carcinoma" (8 trials). Many other conditions were trialed in "Mary Greeley Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Mary Greeley Medical Center
Most popular intervention types in "Mary Greeley Medical Center" are "Drug" (158 trials), "Other" (123 trials), "Biological" (86 trials), "Procedure" (60 trials) and "Radiation" (26 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (58 trials), "Laboratory Biomarker Analysis" (52 trials), "Questionnaire Administration" (37 trials), "Computed Tomography" (35 trials) and "Biospecimen Collection" (33 trials). Other intervention names were less common.
Clinical Trials Genders at Mary Greeley Medical Center
The vast majority of trials in "Mary Greeley Medical Center" are
165 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Mary Greeley Medical Center
Currently, there are NaN active trials in "Mary Greeley Medical Center".
undefined are not yet recruiting,
76 are recruiting,
84 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 24 completed trials in Mary Greeley Medical Center,
3 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Mary Greeley Medical Center, 3 "Phase 1"
clinical trials were conducted, 102 "Phase 2" clinical
trials and 98 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".